Interacting Drugs |
Zidovudine and lamivudine vs DOXOrubicin (Liposomal) |
Security Level |
 |
Mechanism |
DOXOrubicin (Liposomal): May enhance the adverse/toxic effect of Zidovudine. DOXOrubicin (Liposomal) may diminish the therapeutic effect of Zidovudine. |
Management |
Consider therapy modification |
Zidovudine and lamivudine vs DOXOrubicin (Liposomal)
Post Review about Zidovudine and lamivudine vs DOXOrubicin (Liposomal) Click here to cancel reply.
Other Interactions of Zidovudine and lamivudine
Other Interactions of DOXOrubicin (Liposomal)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.